GrippeEspagneV1, Main, Exploration, bibRecord, 000219

Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study.

Identifieur interne : 000219 ( Main/Exploration ); précédent : 000218; suivant : 000220

Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study.

Auteurs : S. Jimenez-Jorge [Espagne] ; F. Pozo ; S. De Mateo ; C. Delgado-Sanz ; I. Casas ; M. Garcia-Cenoz ; J. Castilla ; R. Sancho ; L. Etxebarriarteun-Aranzabal ; C. Quinones ; E. Martinez ; T. Vega ; A. Garcia ; J. Gimenez ; J M Vanrell ; D. Castrillejo ; A. Larrauri

Source :

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [ 1560-7917 ] ; 2014.

RBID : pubmed:24626206

Descripteurs français

KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Enfant (MeSH), Enfant d'âge préscolaire (MeSH), Espagne (épidémiologie), Femelle (MeSH), Grippe humaine (prévention et contrôle), Grippe humaine (virologie), Grippe humaine (épidémiologie), Humains (MeSH), Jeune adulte (MeSH), Modèles logistiques (MeSH), Mâle (MeSH), Nourrisson (MeSH), Sous-type H1N1 du virus de la grippe A (génétique), Sous-type H1N1 du virus de la grippe A (immunologie), Sous-type H1N1 du virus de la grippe A (isolement et purification), Sous-type H3N2 du virus de la grippe A (génétique), Sous-type H3N2 du virus de la grippe A (immunologie), Sous-type H3N2 du virus de la grippe A (isolement et purification), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Surveillance de la population (MeSH), Vaccination (MeSH), Vaccins antigrippaux (administration et posologie), Études cas-témoins (MeSH).
MESH :
- administration et posologie : Vaccins antigrippaux.
- génétique : Sous-type H1N1 du virus de la grippe A, Sous-type H3N2 du virus de la grippe A.
- immunologie : Sous-type H1N1 du virus de la grippe A, Sous-type H3N2 du virus de la grippe A.
- isolement et purification : Sous-type H1N1 du virus de la grippe A, Sous-type H3N2 du virus de la grippe A.
- prévention et contrôle : Grippe humaine.
- virologie : Grippe humaine.
- épidémiologie : Espagne, Grippe humaine.
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Jeune adulte, Modèles logistiques, Mâle, Nourrisson, Sujet âgé, Sujet âgé de 80 ans ou plus, Surveillance de la population, Vaccination, Études cas-témoins.
Wicri :
- geographic : Espagne.

English descriptors

KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Case-Control Studies (MeSH), Child (MeSH), Child, Preschool (MeSH), Female (MeSH), Humans (MeSH), Infant (MeSH), Influenza A Virus, H1N1 Subtype (genetics), Influenza A Virus, H1N1 Subtype (immunology), Influenza A Virus, H1N1 Subtype (isolation & purification), Influenza A Virus, H3N2 Subtype (genetics), Influenza A Virus, H3N2 Subtype (immunology), Influenza A Virus, H3N2 Subtype (isolation & purification), Influenza Vaccines (administration & dosage), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (virology), Logistic Models (MeSH), Male (MeSH), Middle Aged (MeSH), Outcome Assessment, Health Care (MeSH), Population Surveillance (MeSH), Spain (epidemiology), Vaccination (MeSH), Young Adult (MeSH).
MESH :
- chemical , administration & dosage : Influenza Vaccines.
- geographic , epidemiology : Spain.
- epidemiology : Influenza, Human.
- genetics : Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype.
- immunology : Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype.
- isolation & purification : Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype.
- prevention & control : Influenza, Human.
- virology : Influenza, Human.
- Adolescent, Adult, Aged, Aged, 80 and over, Case-Control Studies, Child, Child, Preschool, Female, Humans, Infant, Logistic Models, Male, Middle Aged, Outcome Assessment, Health Care, Population Surveillance, Vaccination, Young Adult.

Abstract

Adjusted early estimates of the 2013/14 influenza vaccine effectiveness (VE) in Spain for all age groups was 35% (95% CI: -9 to 62), 33% (95% CI: -33 to 67) and 28% (95% CI: -33 to 61) against any influenza virus type, A(H1N1)pdm09 and A(H3N2) viruses, respectively. For the population targeted for vaccination, the adjusted VE was 44% (95% CI: -11 to 72), 36% (95% CI: -64 to 75) and 42% (95% CI: -29 to 74), respectively. These preliminary results in Spain suggest a suboptimal protective effect of the vaccine against circulating influenza viruses.

DOI: 10.2807/1560-7917.es2014.19.9.20727
PubMed: 24626206

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 00214
to stream Main, to step Curation: 000214

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study.</title>
<author><name sortKey="Jimenez Jorge, S" sort="Jimenez Jorge, S" uniqKey="Jimenez Jorge S" first="S" last="Jimenez-Jorge">S. Jimenez-Jorge</name>
<affiliation wicri:level="3"><nlm:affiliation>National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>National Centre of Epidemiology, Institute of Health Carlos III, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pozo, F" sort="Pozo, F" uniqKey="Pozo F" first="F" last="Pozo">F. Pozo</name>
</author>
<author><name sortKey="De Mateo, S" sort="De Mateo, S" uniqKey="De Mateo S" first="S" last="De Mateo">S. De Mateo</name>
</author>
<author><name sortKey="Delgado Sanz, C" sort="Delgado Sanz, C" uniqKey="Delgado Sanz C" first="C" last="Delgado-Sanz">C. Delgado-Sanz</name>
</author>
<author><name sortKey="Casas, I" sort="Casas, I" uniqKey="Casas I" first="I" last="Casas">I. Casas</name>
</author>
<author><name sortKey="Garcia Cenoz, M" sort="Garcia Cenoz, M" uniqKey="Garcia Cenoz M" first="M" last="Garcia-Cenoz">M. Garcia-Cenoz</name>
</author>
<author><name sortKey="Castilla, J" sort="Castilla, J" uniqKey="Castilla J" first="J" last="Castilla">J. Castilla</name>
</author>
<author><name sortKey="Sancho, R" sort="Sancho, R" uniqKey="Sancho R" first="R" last="Sancho">R. Sancho</name>
</author>
<author><name sortKey="Etxebarriarteun Aranzabal, L" sort="Etxebarriarteun Aranzabal, L" uniqKey="Etxebarriarteun Aranzabal L" first="L" last="Etxebarriarteun-Aranzabal">L. Etxebarriarteun-Aranzabal</name>
</author>
<author><name sortKey="Quinones, C" sort="Quinones, C" uniqKey="Quinones C" first="C" last="Quinones">C. Quinones</name>
</author>
<author><name sortKey="Martinez, E" sort="Martinez, E" uniqKey="Martinez E" first="E" last="Martinez">E. Martinez</name>
</author>
<author><name sortKey="Vega, T" sort="Vega, T" uniqKey="Vega T" first="T" last="Vega">T. Vega</name>
</author>
<author><name sortKey="Garcia, A" sort="Garcia, A" uniqKey="Garcia A" first="A" last="Garcia">A. Garcia</name>
</author>
<author><name sortKey="Gimenez, J" sort="Gimenez, J" uniqKey="Gimenez J" first="J" last="Gimenez">J. Gimenez</name>
</author>
<author><name sortKey="Vanrell, J M" sort="Vanrell, J M" uniqKey="Vanrell J" first="J M" last="Vanrell">J M Vanrell</name>
</author>
<author><name sortKey="Castrillejo, D" sort="Castrillejo, D" uniqKey="Castrillejo D" first="D" last="Castrillejo">D. Castrillejo</name>
</author>
<author><name sortKey="Larrauri, A" sort="Larrauri, A" uniqKey="Larrauri A" first="A" last="Larrauri">A. Larrauri</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24626206</idno>
<idno type="pmid">24626206</idno>
<idno type="doi">10.2807/1560-7917.es2014.19.9.20727</idno>
<idno type="wicri:Area/Main/Corpus">00214</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00214</idno>
<idno type="wicri:Area/Main/Curation">000214</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000214</idno>
<idno type="wicri:Area/Main/Exploration">000214</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study.</title>
<author><name sortKey="Jimenez Jorge, S" sort="Jimenez Jorge, S" uniqKey="Jimenez Jorge S" first="S" last="Jimenez-Jorge">S. Jimenez-Jorge</name>
<affiliation wicri:level="3"><nlm:affiliation>National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>National Centre of Epidemiology, Institute of Health Carlos III, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pozo, F" sort="Pozo, F" uniqKey="Pozo F" first="F" last="Pozo">F. Pozo</name>
</author>
<author><name sortKey="De Mateo, S" sort="De Mateo, S" uniqKey="De Mateo S" first="S" last="De Mateo">S. De Mateo</name>
</author>
<author><name sortKey="Delgado Sanz, C" sort="Delgado Sanz, C" uniqKey="Delgado Sanz C" first="C" last="Delgado-Sanz">C. Delgado-Sanz</name>
</author>
<author><name sortKey="Casas, I" sort="Casas, I" uniqKey="Casas I" first="I" last="Casas">I. Casas</name>
</author>
<author><name sortKey="Garcia Cenoz, M" sort="Garcia Cenoz, M" uniqKey="Garcia Cenoz M" first="M" last="Garcia-Cenoz">M. Garcia-Cenoz</name>
</author>
<author><name sortKey="Castilla, J" sort="Castilla, J" uniqKey="Castilla J" first="J" last="Castilla">J. Castilla</name>
</author>
<author><name sortKey="Sancho, R" sort="Sancho, R" uniqKey="Sancho R" first="R" last="Sancho">R. Sancho</name>
</author>
<author><name sortKey="Etxebarriarteun Aranzabal, L" sort="Etxebarriarteun Aranzabal, L" uniqKey="Etxebarriarteun Aranzabal L" first="L" last="Etxebarriarteun-Aranzabal">L. Etxebarriarteun-Aranzabal</name>
</author>
<author><name sortKey="Quinones, C" sort="Quinones, C" uniqKey="Quinones C" first="C" last="Quinones">C. Quinones</name>
</author>
<author><name sortKey="Martinez, E" sort="Martinez, E" uniqKey="Martinez E" first="E" last="Martinez">E. Martinez</name>
</author>
<author><name sortKey="Vega, T" sort="Vega, T" uniqKey="Vega T" first="T" last="Vega">T. Vega</name>
</author>
<author><name sortKey="Garcia, A" sort="Garcia, A" uniqKey="Garcia A" first="A" last="Garcia">A. Garcia</name>
</author>
<author><name sortKey="Gimenez, J" sort="Gimenez, J" uniqKey="Gimenez J" first="J" last="Gimenez">J. Gimenez</name>
</author>
<author><name sortKey="Vanrell, J M" sort="Vanrell, J M" uniqKey="Vanrell J" first="J M" last="Vanrell">J M Vanrell</name>
</author>
<author><name sortKey="Castrillejo, D" sort="Castrillejo, D" uniqKey="Castrillejo D" first="D" last="Castrillejo">D. Castrillejo</name>
</author>
<author><name sortKey="Larrauri, A" sort="Larrauri, A" uniqKey="Larrauri A" first="A" last="Larrauri">A. Larrauri</name>
</author>
</analytic>
<series><title level="j">Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</title>
<idno type="eISSN">1560-7917</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Case-Control Studies (MeSH)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Infant (MeSH)</term>
<term>Influenza A Virus, H1N1 Subtype (genetics)</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza A Virus, H1N1 Subtype (isolation & purification)</term>
<term>Influenza A Virus, H3N2 Subtype (genetics)</term>
<term>Influenza A Virus, H3N2 Subtype (immunology)</term>
<term>Influenza A Virus, H3N2 Subtype (isolation & purification)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Influenza, Human (virology)</term>
<term>Logistic Models (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Outcome Assessment, Health Care (MeSH)</term>
<term>Population Surveillance (MeSH)</term>
<term>Spain (epidemiology)</term>
<term>Vaccination (MeSH)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Espagne (épidémiologie)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (prévention et contrôle)</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Modèles logistiques (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Nourrisson (MeSH)</term>
<term>Sous-type H1N1 du virus de la grippe A (génétique)</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Sous-type H1N1 du virus de la grippe A (isolement et purification)</term>
<term>Sous-type H3N2 du virus de la grippe A (génétique)</term>
<term>Sous-type H3N2 du virus de la grippe A (immunologie)</term>
<term>Sous-type H3N2 du virus de la grippe A (isolement et purification)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Surveillance de la population (MeSH)</term>
<term>Vaccination (MeSH)</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Études cas-témoins (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H3N2 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H3N2 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H3N2 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H3N2 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H3N2 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H3N2 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Case-Control Studies</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Logistic Models</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Outcome Assessment, Health Care</term>
<term>Population Surveillance</term>
<term>Vaccination</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Modèles logistiques</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Surveillance de la population</term>
<term>Vaccination</term>
<term>Études cas-témoins</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Adjusted early estimates of the 2013/14 influenza vaccine effectiveness (VE) in Spain for all age groups was 35% (95% CI: -9 to 62), 33% (95% CI: -33 to 67) and 28% (95% CI: -33 to 61) against any influenza virus type, A(H1N1)pdm09 and A(H3N2) viruses, respectively. For the population targeted for vaccination, the adjusted VE was 44% (95% CI: -11 to 72), 36% (95% CI: -64 to 75) and 42% (95% CI: -29 to 74), respectively. These preliminary results in Spain suggest a suboptimal protective effect of the vaccine against circulating influenza viruses.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24626206</PMID>
<DateCompleted><Year>2014</Year>
<Month>08</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1560-7917</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>19</Volume>
<Issue>9</Issue>
<PubDate><Year>2014</Year>
<Month>Mar</Month>
<Day>06</Day>
</PubDate>
</JournalIssue>
<Title>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</Title>
<ISOAbbreviation>Euro Surveill.</ISOAbbreviation>
</Journal>
<ArticleTitle>Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">20727</ELocationID>
<Abstract><AbstractText>Adjusted early estimates of the 2013/14 influenza vaccine effectiveness (VE) in Spain for all age groups was 35% (95% CI: -9 to 62), 33% (95% CI: -33 to 67) and 28% (95% CI: -33 to 61) against any influenza virus type, A(H1N1)pdm09 and A(H3N2) viruses, respectively. For the population targeted for vaccination, the adjusted VE was 44% (95% CI: -11 to 72), 36% (95% CI: -64 to 75) and 42% (95% CI: -29 to 74), respectively. These preliminary results in Spain suggest a suboptimal protective effect of the vaccine against circulating influenza viruses.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jimenez-Jorge</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pozo</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>de Mateo</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Delgado-Sanz</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Casas</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y"><LastName>Garcia-Cenoz</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Castilla</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sancho</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Etxebarriarteun-Aranzabal</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Quinones</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Martinez</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Vega</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Garcia</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gimenez</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Vanrell</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Castrillejo</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Larrauri</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><CollectiveName>Spanish Influenza Sentinel Surveillance System (SISS)</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>03</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Sweden</Country>
<MedlineTA>Euro Surveill</MedlineTA>
<NlmUniqueID>100887452</NlmUniqueID>
<ISSNLinking>1025-496X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053122" MajorTopicYN="N">Influenza A Virus, H3N2 Subtype</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017063" MajorTopicYN="Y">Outcome Assessment, Health Care</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>3</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>3</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>8</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24626206</ArticleId>
<ArticleId IdType="doi">10.2807/1560-7917.es2014.19.9.20727</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Communauté de Madrid</li>
</region>
<settlement><li>Madrid</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Casas, I" sort="Casas, I" uniqKey="Casas I" first="I" last="Casas">I. Casas</name>
<name sortKey="Castilla, J" sort="Castilla, J" uniqKey="Castilla J" first="J" last="Castilla">J. Castilla</name>
<name sortKey="Castrillejo, D" sort="Castrillejo, D" uniqKey="Castrillejo D" first="D" last="Castrillejo">D. Castrillejo</name>
<name sortKey="De Mateo, S" sort="De Mateo, S" uniqKey="De Mateo S" first="S" last="De Mateo">S. De Mateo</name>
<name sortKey="Delgado Sanz, C" sort="Delgado Sanz, C" uniqKey="Delgado Sanz C" first="C" last="Delgado-Sanz">C. Delgado-Sanz</name>
<name sortKey="Etxebarriarteun Aranzabal, L" sort="Etxebarriarteun Aranzabal, L" uniqKey="Etxebarriarteun Aranzabal L" first="L" last="Etxebarriarteun-Aranzabal">L. Etxebarriarteun-Aranzabal</name>
<name sortKey="Garcia Cenoz, M" sort="Garcia Cenoz, M" uniqKey="Garcia Cenoz M" first="M" last="Garcia-Cenoz">M. Garcia-Cenoz</name>
<name sortKey="Garcia, A" sort="Garcia, A" uniqKey="Garcia A" first="A" last="Garcia">A. Garcia</name>
<name sortKey="Gimenez, J" sort="Gimenez, J" uniqKey="Gimenez J" first="J" last="Gimenez">J. Gimenez</name>
<name sortKey="Larrauri, A" sort="Larrauri, A" uniqKey="Larrauri A" first="A" last="Larrauri">A. Larrauri</name>
<name sortKey="Martinez, E" sort="Martinez, E" uniqKey="Martinez E" first="E" last="Martinez">E. Martinez</name>
<name sortKey="Pozo, F" sort="Pozo, F" uniqKey="Pozo F" first="F" last="Pozo">F. Pozo</name>
<name sortKey="Quinones, C" sort="Quinones, C" uniqKey="Quinones C" first="C" last="Quinones">C. Quinones</name>
<name sortKey="Sancho, R" sort="Sancho, R" uniqKey="Sancho R" first="R" last="Sancho">R. Sancho</name>
<name sortKey="Vanrell, J M" sort="Vanrell, J M" uniqKey="Vanrell J" first="J M" last="Vanrell">J M Vanrell</name>
<name sortKey="Vega, T" sort="Vega, T" uniqKey="Vega T" first="T" last="Vega">T. Vega</name>
</noCountry>
<country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Jimenez Jorge, S" sort="Jimenez Jorge, S" uniqKey="Jimenez Jorge S" first="S" last="Jimenez-Jorge">S. Jimenez-Jorge</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000219 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000219 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeEspagneV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:24626206
   |texte=   Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:24626206" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeEspagneV1

This area was generated with Dilib version V0.6.37.
Data generation: Fri Sep 25 11:01:38 2020. Site generation: Sat Feb 13 17:38:04 2021

	Serveur d'exploration sur la grippe en Espagne
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la grippe en Espagne

Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study.

Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki